ePrints

Extracorporeal Photopheresis (ECP) in the Treatment of Chronic Lung Allograft Dysfunction (CLAD): a prospective, multicentre, open-label, randomised controlled trial studying the addition of ECP to standard care in the treatment of bilateral lung transplant patients with CLAD (E-CLAD UK)

Lookup NU author(s): Professor Andrew FisherORCiD, Professor Helen Hancock, Professor James WasonORCiD, Dr Michael Grayling, Dr Joanne LallyORCiD, Professor Andrew GenneryORCiD, Professor Catherine Exley, Paula BradleyORCiD, Michelle Bardgett, Michael White, Nicola GoudieORCiD, Julia PhillipsonORCiD, Anneka Kershaw, Dr Siân Russell, Professor Luke ValeORCiD, Dr Thomas Chadwick, Andrew Bryant, Alex Bevin-Nicholls, Laura Frisby

Downloads

• Published version [.pdf]

Licence

This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License (CC BY-NC 4.0).

Publication metadata

Author(s): Fisher AJ, Carby M, Thompson R, Parmar J, Alaloul M, Santhanakrishnan K, Hancock H, Wason J, Grayling M, Hasenfuss J, Lally J, Gennery A, Exley C, Lordan J, Bradley P, Flinn A, Bardgett M, White M, Goudie N, Phillipson J, Kershaw A, Smith H, Russell S, Vale L, Chadwick T, Bryant A, Bevin-Nicholls A, Frisby L, Johnson R

Publication type: Article

Publication status: Published

Journal: BMJ Open Respiratory Research

Year: 2024

Volume: 11

Issue: 1

Online publication date: 09/05/2024

Acceptance date: 22/04/2024

Date deposited: 30/05/2024

ISSN (electronic): 2052-4439

Publisher: BMJ Group

URL: https://doi.org/10.1136/bmjresp-2023-001995

DOI: 10.1136/bmjresp-2023-001995

Data Access Statement: All data relevant to the study are included in the article or uploaded as supplementary information

Altmetrics

Share